2021
Factors affecting the resolution of acute non-infectious anterior scleritis
Abdel-Aty A, Kombo N. Factors affecting the resolution of acute non-infectious anterior scleritis. British Journal Of Ophthalmology 2021, 106: 1672-1677. PMID: 34210671, DOI: 10.1136/bjophthalmol-2021-318808.Peer-Reviewed Original ResearchConceptsNon-steroidal anti-inflammatory drugsSystemic non-steroidal anti-inflammatory drugsNon-infectious anterior scleritisAnterior scleritisHispanic raceNSAID useTumor necrosis factor-alpha inhibitorsNecrosis factor-alpha inhibitorsCox proportionate hazards modelDiffuse anterior scleritisNodular anterior scleritisRecords of patientsFuture prospective studiesDifferent patient groupsAnti-inflammatory drugsAcute scleritisBilateral scleritisNecrotising scleritisSystemic corticosteroidsImmunomodulatory therapyTopical corticosteroidsPatient characteristicsLupus erythematosusLupus diagnosisPatient group
2015
A Therapeutic Trial of Valganciclovir in Patients with Uveitis and Positive Epstein-Barr virus Early Antigen D IgG Titers
Boonsopon S, Maghsoudlou A, Kombo NE, Foster CS. A Therapeutic Trial of Valganciclovir in Patients with Uveitis and Positive Epstein-Barr virus Early Antigen D IgG Titers. European Journal Of Ophthalmology 2015, 26: 30-35. PMID: 26350994, DOI: 10.5301/ejo.5000673.Peer-Reviewed Original ResearchConceptsPositive Epstein-Barr virusEpstein-Barr virusTherapeutic trialsEBV infection/reactivationInfection/reactivationMassachusetts Eye ResearchCauses of uveitisRetrospective chart reviewImmunoglobulin G titersSurgery institutionsValganciclovir therapyEBV reactivationImmunomodulatory therapyIntraocular inflammationChart reviewIgG titersPersistent inflammationEA antibodyEBV-EAG titersValganciclovirNegative studiesUveitisPatientsInflammation